Patents by Inventor Leslie Boux

Leslie Boux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EFFICIENT PRODUCTION OF PEPTIDES
    Publication number: 20180187232
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Application
    Filed: November 16, 2017
    Publication date: July 5, 2018
    Inventors: Michael H.B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • EFFICIENT PRODUCTION OF PEPTIDES
    Publication number: 20160208304
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 21, 2016
    Inventors: Michael H.B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • Efficient production of peptides
    Patent number: 9266934
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: February 23, 2016
    Assignees: The Regents of the University of Colorado, a body corporate, AmideBio, LLC
    Inventors: Michael H. B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • EFFICIENT PRODUCTION OF PEPTIDES
    Publication number: 20150017685
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Application
    Filed: July 8, 2014
    Publication date: January 15, 2015
    Inventors: Michael H. B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • Efficient production of peptides
    Patent number: 8796431
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Grant
    Filed: November 9, 2010
    Date of Patent: August 5, 2014
    Assignees: The Regents of the University of Colorado, a body corporate, AmideBio LLC
    Inventors: Michael H. B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • Efficient Production of Peptides
    Publication number: 20110112990
    Abstract: The present invention relates to processes for the production of peptides, and the peptides produced accordingly. Peptides produced according to the invention may be produced more efficiently than peptides produced according to prior art processes. The production process of the invention may lead to advantages in yield, purity, and/or price. Methods of marketing peptides are also disclosed.
    Type: Application
    Filed: November 9, 2010
    Publication date: May 12, 2011
    Applicants: The Regents of the University of Colorado, a body corporate, AmideBio LLC
    Inventors: Michael H. B. Stowell, Jonathan Caruthers, Travis Nemkov, Brian Hiester, Leslie Boux, Mikhail Plam
  • Human papilloma virus treatment
    Publication number: 20080063661
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: April 26, 2007
    Publication date: March 13, 2008
    Inventors: John Neefe, Stephen Goldstone, Mark Winnett, Marvin Siegel, Leslie Boux
  • Acellular pertussis vaccines and methods of preparation thereof
    Patent number: 6399076
    Abstract: Acellular pertussis vaccines comprise purified toxin or toxoid thereof, filamentous haemagglutinin, pertactin and fimbrial agglutinogens formulated to confer protection to at least 70% of members of an at-risk population. The fimbrial agglutinogens may be prepared from a Bordetella strain, particularly a B. pertussis strain, by a multiple step procedure involving extraction of the fimbrial agglutinogens from cell paste and concentrating and purifying the extracted material.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: June 4, 2002
    Assignee: Aventis Pasteur Limited
    Inventors: John R. Vose, Raafat E. F. Fahim, Gail E. D. Jackson, Larry U. L. Tan, Andrew Herbert, Leslie Boux, Luis Barreto, John Thipphawong, Michel H. Klein
  • ACELLULAR PERTUSSIS VACCINES AND METHODS OF PREPARATION THEREOF
    Publication number: 20010009666
    Abstract: Acellular pertussis vaccines comprise purified toxin or toxoid thereof, filamentous haemagglutinin, pertactin and fimbrial agglutinogens formulated to confer protection to at least 70% of members of an at-risk population. The fimbrial agglutinogens may be prepared from a Bordetella strain, particularly a B. pertussis strain, by a multiple step procedure involving extraction of the fimbrial agglutinogens from cell paste and concentrating and purifying the extracted material.
    Type: Application
    Filed: June 9, 1998
    Publication date: July 26, 2001
    Inventors: JOHN R VOSE, RAAFAT E F FAHIM, GAIL E D JACKSON, LARRY U L TAN, ANDREW HERBERT, LESLIE BOUX, LUIS BARRETO, JOHN THIPPHAWONG, MICHEL H KLEIN